IGF1 and gestational diabetes: Given the centrality of the IGF system in fetal growth and its dysregulation in GDM, as well as the predicted regulatory role of C19MC miRNAs in this pathway, there is a compelling need to investigate their potential contribution to fetal overgrowth.